Gynaecomastia following solid organ transplantation.
Fischereder
M
M
Klinik und Poliklinik für Innere Medizin II, Klinikum der Universität Regensburg, Regensburg, Germany. michael.fischereder@klinik.uni-regensburg.de
Gräb
C
C
Anthuber
M
M
Krüger
B
B
Zülke
C
C
Jauch
K W
KW
Krämer
B K
BK
D002121:Calcium Channel Blockers / Q000627:therapeutic use; D006177:Gynecomastia / Q000453:epidemiology*; D016027:Heart Transplantation; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology; D016559:Tacrolimus / Q000627:therapeutic use; D013997:Time Factors
D002121:Calcium Channel Blockers; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007166:Immunosuppressive Agents; D016559:Tacrolimus